Javier A Menendez

30PUBLICATIONS
53CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical biochemistry and metabolomics not elsewhere classifiedCancer diagnosisLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Feb 19, 2026
Mitochondrial bioenergetics-SASP crosstalk determines senolytic efficacy in therapy-induced senescence.

Àngela Llop-Hernández, Sara Verdura, Júlia López

|Jun 13, 2025
RETRACTED: Cejuela et al. Metformin and Breast Cancer: Where Are We Now? Int. J. Mol. Sci. 2022, 23, 2705.

Mónica Cejuela, Begoña Martin-Castillo, Javier A Menendez

|Mar 07, 2025
Mitochondrial priming and response to BH3 mimetics in "one-two punch" senogenic-senolytic strategies.

Júlia López, Àngela Llop-Hernández, Sara Verdura

|Sep 30, 2024
Fatty acid synthase (FASN) is a tumor-cell-intrinsic metabolic checkpoint restricting T-cell immunity.

Elisabet Cuyàs, Stefano Pedarra, Sara Verdura

|Dec 30, 2023
Fatty acid synthase (FASN) signalome: A molecular guide for precision oncology.

Javier A Menendez, Elisabet Cuyàs, Jose Antonio Encinar

Pageof 5